Want to see IN:UNICHEMLAB full AI Analyst Report?

Unichem Laboratories Limited (UNICHEMLAB) Price & Analysis

0 Followers

UNICHEMLAB Stock Chart & Stats

₹443.05

-₹12.85(-1.76%)

At close: Jan 08 4:00 PM EST

₹443.05

-₹12.85(-1.76%)

Day’s Range― - ―

52-Week Range₹280.00 - ₹685.95

Previous CloseN/A

Volume14.19K

Average Volume (3M)1.03K

Market Cap

₹36.97B

Enterprise Value₹22.74K

Total Cash (Recent Filing)₹2.99B

Total Debt (Recent Filing)₹5.00B

Price to Earnings (P/E)12.2

Beta1.31

Next Earnings

Nov 04, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)35.91

Shares Outstanding70,405,754

10 Day Avg. Volume1,013

30 Day Avg. Volume1,033

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)0.76

Price to Sales (P/S)0.94

P/FCF Ratio-14.89

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage and a substantial equity base provide financial resilience and reduce dependence on external funding. This gives Unichem greater flexibility to sustain manufacturing, regulatory, and product-development investments through weaker operating periods.

Long-Term Earnings RecoveryThe return from losses in 2023–2024 to profitability in 2025–2026 indicates improving earnings resilience. Although growth has recently moderated, the recovery provides a stronger base for future performance if operating execution continues.

Diversified Pharmaceutical PlatformExposure to branded generics, international formulations, and APIs across multiple therapeutic areas and geographies diversifies revenue sources. Manufacturing capabilities and regulatory compliance can support recurring supply and market access over time.

Bears Say

Weak Cash ConversionPersistent negative operating and free cash flow means reported earnings are not converting into liquidity. Continued cash burn or heavy reinvestment could increase reliance on funding flexibility and constrain investment if operating conditions weaken.

Thin Operating ProfitabilityA thin operating margin leaves limited protection against manufacturing costs, pricing pressure, or product-mix changes. Historical gross-margin volatility also suggests that the recent earnings recovery may not yet represent a consistently durable profit structure.

Uneven Growth And ReturnsThe latest revenue contraction and historically weak returns indicate inconsistent use of the company’s capital base. Without sustained growth and stronger returns, balance-sheet strength may provide stability without translating into durable shareholder value creation.

Unichem Laboratories Limited News

Exchange Seeks Clarification as Unichem Labs Shares See Volume Surge

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has provided an announcement. A significant spike in trading volume has been...

2d ago

Unichem Labs Files FY 2026 Business Responsibility and Sustainability Report

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has issued an update. Unichem Laboratories has submitted its Business Responsibility and...

2M ago

Unichem Sets August 11 AGM to Ratify Accounts, Extend CEO Tenure and Cost Audit Mandate

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an announcement. Unichem Laboratories Limited has scheduled its 63rd Annual...

2M ago

Unichem Publishes FY26 Results in Newspapers, Notifies Exchanges

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an update. Unichem Laboratories has notified stock exchanges that its...

3M ago

Unichem’s U.S. Unit Voluntarily Recalls Buspirone Tablets on Quality Deviation

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) just unveiled an announcement. Unichem Pharmaceuticals (USA), Inc., the U.S. arm of...

5M ago

Unichem Shareholders Clear Director Appointment and Key Related-Party Deals via Postal Ballot

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an announcement. Unichem Laboratories has announced the results of a...

5M ago

Unichem Laboratories Settles European Commission Fine

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has shared an update. Unichem Laboratories Limited has announced the payment of...

10M ago

Unichem Laboratories Faces Demand Notice from NPPA for Alleged Overcharging

The latest update is out from Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ). Unichem Laboratories Limited has received a...

11M ago

Unichem Laboratories Receives USFDA Inspection Report

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) just unveiled an announcement. Unichem Laboratories Limited announced that it has received...

1y ago

Unichem Laboratories Updates RTA Contact Details

Unichem Laboratories Limited ( ($IN:UNICHEMLAB) ) has provided an announcement. Unichem Laboratories Limited announced a change in the...

1y ago

UNICHEMLAB FAQ

What was Unichem Laboratories Limited’s price range in the past 12 months?

Unichem Laboratories Limited lowest stock price was ₹280.00 and its highest was ₹685.95 in the past 12 months.

What is Unichem Laboratories Limited’s market cap?

Unichem Laboratories Limited’s market cap is ₹36.97B.

When is Unichem Laboratories Limited’s upcoming earnings report date?

Unichem Laboratories Limited’s upcoming earnings report date is Nov 04, 2026 which is in 69 days.

How were Unichem Laboratories Limited’s earnings last quarter?

Unichem Laboratories Limited released its earnings results on Aug 11, 2026. The company reported ₹5.89 earnings per share for the quarter, beating the consensus estimate of N/A by ₹5.89.

Is Unichem Laboratories Limited overvalued?

According to Wall Street analysts Unichem Laboratories Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Unichem Laboratories Limited pay dividends?

Unichem Laboratories Limited pays a Annually dividend of ₹4 which represents an annual dividend yield of N/A. See more information on Unichem Laboratories Limited dividends here

What is Unichem Laboratories Limited’s EPS estimate?

Unichem Laboratories Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Unichem Laboratories Limited have?

Unichem Laboratories Limited has 70,405,754 shares outstanding.

What happened to Unichem Laboratories Limited’s price movement after its last earnings report?

Unichem Laboratories Limited reported an EPS of ₹5.89 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 13.062%.

Which hedge fund is a major shareholder of Unichem Laboratories Limited?

Currently, no hedge funds are holding shares in IN:UNICHEMLAB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Unichem Laboratories Limited

Unichem Laboratories Limited is an international pharmaceutical company engaged in the development, manufacturing, and commercialization of a wide array of medicinal products. The firm's portfolio features finished pharmaceutical formulations designed to treat numerous health conditions, including those related to gastroenterology, cardiovascular health, diabetes, mental health, neurological disorders, bacterial and other infectious diseases, and pain relief. Beyond these formulations, Unichem also provides active pharmaceutical ingredients (APIs) and offers contract manufacturing solutions. This enterprise was established in 1944 and operates from its corporate headquarters in Mumbai, India.